274 related articles for article (PubMed ID: 23326356)
1. Ginkgo biloba extract and long-term cognitive decline: a 20-year follow-up population-based study.
Amieva H; Meillon C; Helmer C; Barberger-Gateau P; Dartigues JF
PLoS One; 2013; 8(1):e52755. PubMed ID: 23326356
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and Safety Profile of Ginkgo biloba Standardized Extract (EGb761®) in Patients with Amnestic Mild Cognitive Impairment.
Băjenaru O; Prada G; Antochi F; Jianu C; Tudose C; Cuciureanu A; Docu AA; Perrot V; Avram M; Tiu C
CNS Neurol Disord Drug Targets; 2021; 20(4):378-384. PubMed ID: 33557741
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L
J Alzheimers Dis; 2015; 43(2):589-603. PubMed ID: 25114079
[TBL] [Abstract][Full Text] [Related]
4. A pilot trial of piracetam and ginkgo biloba for the treatment of cocaine dependence.
Kampman K; Majewska MD; Tourian K; Dackis C; Cornish J; Poole S; O'Brien C
Addict Behav; 2003 Apr; 28(3):437-48. PubMed ID: 12628617
[TBL] [Abstract][Full Text] [Related]
5. Ginkgo biloba Extract EGb761 Attenuates Hyperhomocysteinemia-induced AD Like Tau Hyperphosphorylation and Cognitive Impairment in Rats.
Zeng K; Li M; Hu J; Mahaman YAR; Bao J; Huang F; Xia Y; Liu X; Wang Q; Wang JZ; Yang Y; Liu R; Wang X
Curr Alzheimer Res; 2018; 15(1):89-99. PubMed ID: 28847282
[TBL] [Abstract][Full Text] [Related]
6. Ginkgo biloba for cognitive impairment and dementia.
Birks J; Grimley Evans J
Cochrane Database Syst Rev; 2009 Jan; (1):CD003120. PubMed ID: 19160216
[TBL] [Abstract][Full Text] [Related]
7. Effects of ginkgo biloba extract on the cognitive function and expression profile of inflammatory factors in a rat model of hemorrhagic stroke.
Luo C; Fan LH; Zhang H; Zhao J; Li L; Zhang L; Zhang HX; Ma MM
Neuroreport; 2018 Oct; 29(15):1239-1243. PubMed ID: 30096131
[TBL] [Abstract][Full Text] [Related]
8. [Ginkgo Biloba as a cognitive enhancer].
Arushanian EB; Beĭer EV
Eksp Klin Farmakol; 2008; 71(4):57-63. PubMed ID: 18819443
[TBL] [Abstract][Full Text] [Related]
9. [Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia].
Tariska P; Paksy A
Orv Hetil; 2000 May; 141(22):1189-93. PubMed ID: 10853348
[TBL] [Abstract][Full Text] [Related]
10. Ginkgo biloba for cognitive impairment and dementia.
Birks J; Grimley Evans J
Cochrane Database Syst Rev; 2007 Apr; (2):CD003120. PubMed ID: 17443523
[TBL] [Abstract][Full Text] [Related]
11. Effect of a short- and long-term treatment with Ginkgo biloba extract on amyloid precursor protein levels in a transgenic mouse model relevant to Alzheimer's disease.
Augustin S; Rimbach G; Augustin K; Schliebs R; Wolffram S; Cermak R
Arch Biochem Biophys; 2009 Jan; 481(2):177-82. PubMed ID: 18996078
[TBL] [Abstract][Full Text] [Related]
12. An examination of the efficacy of Ginkgo biloba extract EGb761 on the neuropsychologic functioning of cognitively intact older adults.
Mix JA; Crews WD
J Altern Complement Med; 2000 Jun; 6(3):219-29. PubMed ID: 10890330
[TBL] [Abstract][Full Text] [Related]
13. Effects of Ginkgo biloba extract EGb 761® on cognitive control functions, mental activity of the prefrontal cortex and stress reactivity in elderly adults with subjective memory impairment - a randomized double-blind placebo-controlled trial.
Beck SM; Ruge H; Schindler C; Burkart M; Miller R; Kirschbaum C; Goschke T
Hum Psychopharmacol; 2016 May; 31(3):227-42. PubMed ID: 27147264
[TBL] [Abstract][Full Text] [Related]
14. Ginkgo biloba for cognitive impairment and dementia.
Birks J; Grimley EV; Van Dongen M
Cochrane Database Syst Rev; 2002; (4):CD003120. PubMed ID: 12519586
[TBL] [Abstract][Full Text] [Related]
15. Extract of Ginkgo biloba EGb761 facilitates extinction of conditioned fear measured by fear-potentiated startle.
Yang YL; Su YW; Ng MC; Chao PK; Tung LC; Lu KT
Neuropsychopharmacology; 2007 Feb; 32(2):332-42. PubMed ID: 16554745
[TBL] [Abstract][Full Text] [Related]
16. Intra-amygdaloid infusion of Ginkgo biloba leaf extract (EGb761) facilitates fear-potentiated startle in rats.
Yang YL; Hsieh CW; Wo YY; Yang YC; Lu KT
Psychopharmacology (Berl); 2009 Jan; 202(1-3):187-96. PubMed ID: 18563393
[TBL] [Abstract][Full Text] [Related]
17. Interaction between psychological and pharmacological treatment in cognitive impairment.
Deberdt W
Life Sci; 1994; 55(25-26):2057-66. PubMed ID: 7997065
[TBL] [Abstract][Full Text] [Related]
18. The acute nootropic effects of Ginkgo biloba in healthy older human subjects: a preliminary investigation.
Nathan PJ; Ricketts E; Wesnes K; Mrazek L; Greville W; Stough C
Hum Psychopharmacol; 2002 Jan; 17(1):45-9. PubMed ID: 12404706
[TBL] [Abstract][Full Text] [Related]
19. Histopathological, immunohistochemical, and stereological analysis of the effect of Ginkgo biloba (Egb761) on the hippocampus of rats exposed to long-term cellphone radiation.
Gevrek F
Histol Histopathol; 2018 May; 33(5):463-473. PubMed ID: 29120031
[TBL] [Abstract][Full Text] [Related]
20. Vasodilators and nootropics as predictors of dementia and mortality in the PAQUID cohort.
Dartigues JF; Carcaillon L; Helmer C; Lechevallier N; Lafuma A; Khoshnood B
J Am Geriatr Soc; 2007 Mar; 55(3):395-9. PubMed ID: 17341242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
